Neratinib

About

Therapy type: Targeted therapy

Therapy strategy: HER2 inhibition

Mappings

NCI Thesaurus: Neratinib (ncit:C49094)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) HER2-positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) HER2-positive Invasive Breast Carcinoma Capecitabine, Neratinib
Sensitivity (+) ER positive, HER2-positive, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, HER2-positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) HER2-positive, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, ERBB2 amplification, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, ERBB2 amplification Invasive Breast Carcinoma Neratinib
Sensitivity (+) ERBB2 amplification, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, HER2-positive, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, HER2-positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) HER2-positive, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, ERBB2 amplification, PR positive Invasive Breast Carcinoma Neratinib
Sensitivity (+) ER positive, ERBB2 amplification Invasive Breast Carcinoma Neratinib
Sensitivity (+) ERBB2 amplification, PR positive Invasive Breast Carcinoma Neratinib